Angela Cenci Nilsson

Professor
More filtering options
  1. 2020
  2. Reply to: Letter to Editor by Chaudhuri, Jenner, Antonini

    Hauser, R. A., Eidelberg, D., Pahwa, R., Riggare, S. & M. Angela Cenci, 2020 May, In : Movement Disorders. 35, 5, p. 901-901 1 p.

    Research output: Contribution to journalLetter

  3. Preface: The evolving scenario of Parkinson's research

    Anders Björklund & M. Angela Cenci, 2020 Apr 1, Recent Advances in Parkinson's Disease. Björklund, A. & Cenci, M. A. (eds.). 1 ed. Elsevier Science Publishers B.V., p. xix-xx 2 p. (Progress in Brain Research; vol. 252).

    Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

  4. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease

    Irene Sebastianutto, Goyet, E., Andreoli, L., Font-Ingles, J., Moreno-Delgado, D., Bouquier, N., Jahannault-Talignani, C., Moutin, E., Di Menna, L., Maslava, N., Pin, J. P., Fagni, L., Nicoletti, F., Ango, F., M. Angela Cenci & Perroy, J., 2020 Mar 2, In : Journal of Clinical Investigation. 130, 3, p. 1168-1184

    Research output: Contribution to journalArticle

  5. Animal models for preclinical Parkinson´s research: An update and critical appraisal

    Angela Cenci Nilsson & Anders Björklund, 2020, Recent Advances in Parkinson's Disease. Elsevier, Vol. 252. p. 27-59 (Progress in Brain Research; vol. 252).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  6. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications

    Kuter, K. Z., M. Angela Cenci & Carta, A. R., 2020, Recent Advances in Parkinson's Disease. Björklund, A. & Cenci, M. A. (eds.). Elsevier Science Publishers B.V., p. 131-168 38 p. (Progress in Brain Research; vol. 252).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  7. 2019
  8. Dyskinesia matters

    M. Angela Cenci, Riggare, S., Pahwa, R., Eidelberg, D. & Hauser, R. A., 2019, In : Movement Disorders.

    Research output: Contribution to journalArticle

  9. Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease

    Francardo, V., Geva, M., Bez, F., Denis, Q., Steiner, L., Hayden, M. R. & M. Angela Cenci, 2019, In : Neurotherapeutics. 16, 2, p. 465-479

    Research output: Contribution to journalArticle

  10. 2018
  11. Animal models of l-dopa-induced dyskinesia in Parkinson's disease

    M. Angela Cenci & Crossman, A. R., 2018 Jun 1, In : Movement Disorders. 33, 6, p. 889-899

    Research output: Contribution to journalReview article

  12. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies

    Refolo, V., Bez, F., Polissidis, A., Kuzdas-Wood, D., Sturm, E., Kamaratou, M., Poewe, W., Stefanis, L., M. Angela Cenci, Romero-Ramos, M., Wenning, G. K. & Stefanova, N., 2018 Jan 3, In : Acta neuropathologica communications. 6, 1, p. 1-24

    Research output: Contribution to journalArticle

  13. On the neuronal circuitry mediating l-DOPA-induced dyskinesia

    M. Angela Cenci, Henrik Jörntell & Per Petersson, 2018, In : Journal of Neural Transmission. 125, 8, p. 1157-1169

    Research output: Contribution to journalArticle

  14. 2017
  15. CK2 oppositely modulates L-DOPA-induced dyskinesia via striatal projection neurons expressing D1 or D2 receptors

    Cortés, M., Malave, L., Castello, J., Flajolet, M., M. Angela Cenci, Friedman, E. & Rebholz, H., 2017 Dec 6, In : Journal of Neuroscience. 37, 49, p. 11930-11946 17 p.

    Research output: Contribution to journalArticle

  16. Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia

    Lerner, R. P., Francardo, V., Fujita, K., Bimpisidis, Z., Jourdain, V. A., Tang, C. C., Dewey, S. L., Chaly, T., M. Angela Cenci & Eidelberg, D., 2017 Dec 1, In : Scientific Reports. 7, 1, 16005.

    Research output: Contribution to journalArticle

  17. Translating scientific advances into disease-modifying therapies for Parkinson's Disease

    M. Angela Cenci & Olanow, C. W., 2017 Dec 1, In : Experimental Neurology. 298, p. 135-136 2 p.

    Research output: Contribution to journalArticle

  18. Etiology and pathogenesis of parkinson’s disease

    Jonathan Timpka, Maria Angela Cenci & Per Odin, 2017, Movement Disorders Curricula. Springer, p. 95-101 7 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  19. Molecular Mechanisms of L-DOPA-Induced Dyskinesia

    Angela Cenci Nilsson, 2017, Handbook of Behavioral Neuroscience. The Association for the Study of Animal Behaviour / Elsevier B.V., Vol. 24. p. 857-871 15 p. (Handbook of Behavioral Neuroscience; vol. 24).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  20. Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease

    Francardo, V., Schmitz, Y., Sulzer, D. & M. Angela Cenci, 2017, In : Experimental Neurology. 298, Pt. B, p. 137-147

    Research output: Contribution to journalArticle

  21. 2016
  22. Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model

    Lerner, R. P., Bimpisidis, Z., Agorastos, S., Scherrer, S., Dewey, S. L., Angela Cenci Nilsson & Eidelberg, D., 2016 Dec 1, In : Neurobiology of Disease. 96, p. 31-37 7 p.

    Research output: Contribution to journalArticle

  23. Oral and infusion levodopa therapy in the management of Parkinson’s disease

    M. Angela Cenci-Nilsson & Per Odin, 2016 Jan 1, Parkinson's Disease: Current and Future Therapeutics and Clinical Trials. Cambridge University Press, p. 63-75

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  24. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.

    Marongiu, R., Arango-Lievano, M., Francardo, V., Morgenstern, P., Zhang, X., Angela Cenci Nilsson, Svenningsson, P., Greengard, P. & Kaplitt, M. G., 2016, In : Proceedings of the National Academy of Sciences. 113, 5, p. 1423-1428

    Research output: Contribution to journalArticle

  25. On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.

    Carta, M. & Angela Cenci Nilsson, 2016, In : Movement Disorders. 31, 1, p. 149

    Research output: Contribution to journalLetter

  26. Signaling mechanisms in L-DOPA-induced dyskinesia

    Cristina Alcacer, Francardo, V. & Angela Cenci Nilsson, 2016, The Basal Ganglia: Novel Perspectives on Motor and Cognitive Functions. Soghomonian, J-J. (ed.). Springer International Publishing, p. 155-188

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  27. 2015
  28. Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.

    Iderberg, H., McCreary, A. C., Varney, M. A., Angela Cenci Nilsson & Newman-Tancredi, A., 2015, In : Neuropharmacology. 93, p. 52-67

    Research output: Contribution to journalArticle

  29. A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine

    Brehm, N., Bez, F., Carlsson, T., Kern, B., Gispert, S., Auburger, G. & Angela Cenci Nilsson, 2015, In : Molecular Neurobiology. 52, 3, p. 1152-1164

    Research output: Contribution to journalArticle

  30. Increased CSF biomarkers of angiogenesis in Parkinson disease.

    Shorena Janelidze, Daniel Lindqvist, Francardo, V., Sara Hall, Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., Danielle van Westen, Elisabet Londos, Angela Cenci Nilsson & Oskar Hansson, 2015, In : Neurology. 85, 21, p. 1834-1842

    Research output: Contribution to journalArticle

  31. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.

    Shen, W., Plotkin, J. L., Francardo, V., Ko, W. K. D., Xie, Z., Li, Q., Tim Fieblinger, Wess, J., Neubig, R. R., Lindsley, C. W., Conn, P. J., Greengard, P., Bezard, E., Angela Cenci Nilsson & Surmeier, D. J., 2015, In : Neuron. 88, 4, p. 762-773

    Research output: Contribution to journalArticle

  32. NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.

    Iderberg, H., McCreary, A. C., Varney, M. A., Kleven, M. S., Koek, W., Bardin, L., Depoortère, R., Angela Cenci Nilsson & Newman-Tancredi, A., 2015, In : Experimental Neurology. 271, May 30, p. 335-350

    Research output: Contribution to journalArticle

  33. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

    Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., Fisone, G., Jon Stoessl, A., Bourdenx, M., Engeln, M., Navailles, S., De Deurwaerdère, P., Ko, W. K. D., Simola, N., Morelli, M., Groc, L. & 16 others, Rodriguez, M-C., Gurevich, E. V., Quik, M., Morari, M., Mellone, M., Gardoni, F., Tronci, E., Guehl, D., Tison, F., Crossman, A. R., Kang, U. J., Steece-Collier, K., Fox, S., Carta, M., Angela Cenci Nilsson & Bézard, E., 2015, In : Progress in Neurobiology. 132, Jul 21, p. 96-168

    Research output: Contribution to journalReview article

  34. Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.

    Iderberg, H., Maslava, N., Thompson, A. D., Bubser, M., Niswender, C. M., Hopkins, C. R., Lindsley, C. W., Conn, P. J., Jones, C. K. & Angela Cenci Nilsson, 2015, In : Neuropharmacology. 95, p. 121-129

    Research output: Contribution to journalArticle

  35. Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?

    Angela Cenci Nilsson, Francardo, V., O'Sullivan, S. S. & Lindgren, H., 2015, In : Neurobiology of Disease. 82, aug 29, p. 561-573

    Research output: Contribution to journalReview article

  36. 2014
  37. Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease

    Francardo, V., Iderberg, H., Lindgren, H. & Angela Cenci Nilsson, 2014 Oct 29, Movement Disorders: Genetics and Models. LeDoux, M. S. (ed.). 2nd ed. Elsevier Inc., p. 373-386 14 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  38. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.

    Tim Fieblinger, Graves, S. M., Sebel, L. E., Cristina Alcacer, Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Angela Cenci Nilsson & Surmeier, D. J., 2014, In : Nature Communications. 5, 5316.

    Research output: Contribution to journalArticle

  39. Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse

    Francardo, V. & M. Angela Cenci, 2014, In : Parkinsonism and Related Disorders. 20, SUPPL.1, p. S20-S22

    Research output: Contribution to journalArticle

  40. Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

    Heiman, M., Heilbut, A., Francardo, V., Kulicke, R., Fenster, R. J., Kolaczyk, E. D., Mesirov, J. P., Surmeier, D. J., M. Angela Cenci & Greengard, P., 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 12, p. 4578-4583 6 p.

    Research output: Contribution to journalArticle

  41. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.

    Francardo, V., Bez, F., Tadeusz Wieloch, Nissbrandt, H., Karsten Ruscher & Angela Cenci Nilsson, 2014, In : Brain. 137, Apr 22, p. 1998-2014

    Research output: Contribution to journalArticle

  42. Preclinical models of levodopa-induced dyskinesia

    Francardo, V. & M. Angela Cenci, 2014, Levodopa-Induced Dyskinesia in Parkinson's Disease. Fox, S. H. & Brotchie, J. M. (eds.). Springer, p. 335-353 19 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  43. 2013
  44. Bad News for Neuroprotective Therapies in PD?

    Angela Cenci Nilsson & Brooks, D. J., 2013, In : Journal of Parkinson's Disease. 3, 3, p. 271-273

    Research output: Contribution to journalDebate/Note/Editorial

Previous 1 2 3 Next